Heron Therapeutics
HRTX
#8261
Rank
C$0.33 B
Marketcap
C$1.81
Share price
0.00%
Change (1 day)
-26.88%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.32 Billion

According to Heron Therapeutics's latest financial reports the company's total liabilities are C$0.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.38 B12.54%
2023-12-31C$0.34 B5.61%
2022-12-31C$0.32 B10.79%
2021-12-31C$0.29 B94.79%
2020-12-31C$0.14 B4.9%
2019-12-31C$0.14 B13.52%
2018-12-31C$0.12 B-3.36%
2017-12-31C$0.12 B8.78%
2016-12-31C$0.11 B335.57%
2015-12-31C$27.37 M73.21%
2014-12-31C$15.8 M112.36%
2013-12-31C$7.44 M80.19%
2012-12-31C$4.13 M9.96%
2011-12-31C$3.75 M135.61%
2010-12-31C$1.59 M-29.69%
2009-12-31C$2.26 M-55.62%
2008-12-31C$5.1 M-31.49%
2007-12-31C$7.45 M23.37%
2006-12-31C$6.04 M87.72%
2005-12-31C$3.22 M-6.25%
2004-12-31C$3.43 M39.96%
2003-12-31C$2.45 M-33.08%
2002-12-31C$3.66 M-46.89%
2001-12-31C$6.9 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alkermes
ALKS
C$0.82 B 154.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
C$0.78 B 143.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$0.29 B-7.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.72 B 124.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
C$80.86 M-75.00%๐Ÿ‡บ๐Ÿ‡ธ USA